Back
BNP Paribas Vs. Charles River Laboratories International Industry Stock Comparison
Buy
74
BNPQY
BNP Paribas
Last Price:
$43.57
Seasonality Move:
1.19%
Buy
52
CRL
Charles River Laboratories International
Last Price:
$138.79
Seasonality Move:
7.09%
Buy
74
BNP Paribas (BNPQY)
is a Buy
Is BNP Paribas a Buy, Sell or Hold?
-
The current BNP Paribas [BNPQY] share price is $43.57. The Score for BNPQY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
BNPQY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
-
The current Charles River Laboratories International [CRL] share price is $138.79. The Score for CRL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BNPQY Stock Price Chart
What is BNP Paribas's stock price today?
-
The BNP Paribas share price today is $43.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNPQY is experiencing slight selling pressure.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $138.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing selling pressure, which indicates risk of future bearish movement.
BNPQY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 62.3 | Buy |
| Chaikin Money Flow: | -5827 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.41 - 43.11) | Buy |
| Bollinger Bands (100): | (32.39 - 41.81) | Buy |
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.16 | Buy |
| Relative Strength Index (14 RSI): | 59.59 | Buy |
| Chaikin Money Flow: | -798786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.83 - 130.65) | Buy |
| Bollinger Bands (100): | (131.14 - 183.16) | Sell |
BNPQY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.06 | Buy |
| 20-day SMA: | 41.66 | Buy |
| 50-day SMA: | 41.16 | Buy |
| 200-day SMA: | 35.32 | Buy |
| 8-day EMA: | 42.99 | Buy |
| 20-day EMA: | 42.08 | Buy |
| 50-day EMA: | 40.51 | Buy |
| 200-day EMA: | 36.45 | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.74 | Buy |
| 20-day SMA: | 115.49 | Buy |
| 50-day SMA: | 140.7 | Sell |
| 200-day SMA: | 179 | Sell |
| 8-day EMA: | 128.43 | Buy |
| 20-day EMA: | 120.11 | Buy |
| 50-day EMA: | 95.54 | Buy |
| 200-day EMA: | 38.76 | Buy |
BNP Paribas Earnings Growth & BNPQY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.58 per share, and an increase next year of $0.66 per share.
BNP Paribas Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Charles River Laboratories International Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||